Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Slade Health

Slade Health
2012 FOUNDED
M&A STATUS
601-700 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
1 INVESTMENTS
Description

Operator of compounding pharmacy services. The company utilizes Therapeutic Goods Administration (TGA)-licensed manufacturing facilities to supply sterile compounded solutions, enabling hospitals and veterinary clinics across Australia to have tailored and comprehensive pharmacy services.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • 14 Palmer Court
  • Mount Waverley, Victoria 3149
  • Australia

+61 (03) 0000 0000

Slade Health Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Slade Health‘s full profile, request access.

Request full access to PitchBook

Slade Health Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 30-Sep-2015 000000000000000000 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Slade Health Executive Team (3)

Name Title Board
Seat
Contact
Info
David Slade Co-Founder & Chief Executive Officer
Paula Clark Executive Director, Sales and Marketing
Graham Slade Co-Founder